Rare Fat-Loss disorder drug under safety review
Disease control
Completed
This study looked at how the body reacts to metreleptin, a daily injection for generalized lipodystrophy, a rare condition where people lose body fat. Researchers checked for antibodies that might affect the drug's safety or effectiveness. The study involved 11 patients and was d…
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 11:37 UTC